Señales en vivo de AGIO | Maximiza tus Ganancias con Getagraph.com

COMPRAR 111151 min ago

@ $25.84

Emitido: 14 feb 2024 @ 13:56

Retorno: 30.26%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: 1.31 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology...

Stats
Volumen de hoy	842 309
Volumen promedio	760 100
Capitalización de mercado	1.87B
EPS	$-1.720 ( 2024-02-21 )
Próxima fecha de ganancias	( $-1.640 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.59
ATR14	$0.0670 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Fouse Jacqualyn A	Buy	15 934	Common stock
2024-04-10	Fouse Jacqualyn A	Sell	7 791	Common stock
2024-04-08	Fouse Jacqualyn A	Sell	15 934	Restricted stock units
2024-03-07	Foster-cheek Kaye I	Sell	1 285	Common stock
2024-03-05	Foster-cheek Kaye I	Sell	300	Common stock

INSIDER POWER
24.99
Last 100 transactions
Buy: 882 792 \| Sell: 538 174

Volumen Correlación

Largo: -0.38 (neutral)

Corto: -0.65 (weak negative)

Signal:(29.031) Neutral

Agios Pharmaceuticals Inc Correlación

10 Correlaciones Más Positivas
NEOG	0.95
LSXMA	0.941
EAR	0.94
VORB	0.94
LSXMK	0.94
STAF	0.938
VERU	0.936
TTOO	0.936
OCC	0.935
ACCD	0.935

10 Correlaciones Más Negativas
EBSB	-0.952
PAE	-0.944
RMRM	-0.935
THRN	-0.933
SERA	-0.925
CYT	-0.924
BWC	-0.921
ZGNX	-0.919
MLTX	-0.919
GXII	-0.918

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Agios Pharmaceuticals Inc Correlación - Moneda/Commodity

0.25
( neutral )

-0.02
( neutral )

0.00
( neutral )

0.17
( neutral )

0.04
( neutral )

Agios Pharmaceuticals Inc Finanzas

Annual	2023
Ingresos:	$26.82M
Beneficio Bruto:	$17.32M (64.57 %)
EPS:	$-6.33

FY	2023
Ingresos:	$26.82M
Beneficio Bruto:	$17.32M (64.57 %)
EPS:	$-6.33

FY	2022
Ingresos:	$14.24M
Beneficio Bruto:	$12.54M (88.03 %)
EPS:	$-1.360

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$26.55

Financial Reports:

No articles found.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Actualizaciones en tiempo real para Agios Pharmaceuticals Inc [AGIO]

Upcoming Earnings Alert